Figure 5.
(A) Luminol and luminol+Zymosan, and (B) lucigenin dependent CL (low intensity case) of nondiluted blood before and after Hypoxen® treatment (patient R.). 1 – before Hypoxen®, 23.10.09; 2 – after Hypoxen® treatment, 29.12.09.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.